156 related articles for article (PubMed ID: 7614519)
1. Pharmacokinetic considerations for the therapeutic use of carnitine in hemodialysis patients.
Brass EP
Clin Ther; 1995; 17(2):176-85; discussion 175. PubMed ID: 7614519
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
[TBL] [Abstract][Full Text] [Related]
3. Kinetics of carnitine concentration after switching from oral administration to intravenous injection in hemodialysis patients.
Suzuki A; Sakai Y; Hashimoto K; Osawa H; Tsuruoka S
Ren Fail; 2018 Nov; 40(1):196-200. PubMed ID: 29616582
[TBL] [Abstract][Full Text] [Related]
4. Dialysis-related carnitine disorder and levocarnitine pharmacology.
Evans A
Am J Kidney Dis; 2003 Apr; 41(4 Suppl 4):S13-26. PubMed ID: 12751050
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intravenous and oral bolus doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(5):555-62. PubMed ID: 3234464
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of bolus intravenous and oral doses of L-carnitine in healthy subjects.
Harper P; Elwin CE; Cederblad G
Eur J Clin Pharmacol; 1988; 35(1):69-75. PubMed ID: 3220097
[TBL] [Abstract][Full Text] [Related]
8. Oral L-carnitine: metabolite formation and hemodialysis.
Bain MA; Faull R; Milne RW; Evans AM
Curr Drug Metab; 2006 Oct; 7(7):811-6. PubMed ID: 17073580
[TBL] [Abstract][Full Text] [Related]
9. A pharmacokinetic model for L-carnitine in patients receiving haemodialysis.
Fornasini G; Upton RN; Evans AM
Br J Clin Pharmacol; 2007 Sep; 64(3):335-45. PubMed ID: 17506778
[TBL] [Abstract][Full Text] [Related]
10. The Unexpected Effects of L-Carnitine Supplementation on Lipid Metabolism in Hemodialysis Patients.
Katalinic L; Krtalic B; Jelakovic B; Basic-Jukic N
Kidney Blood Press Res; 2018; 43(4):1113-1120. PubMed ID: 30016788
[TBL] [Abstract][Full Text] [Related]
11. Kinetics, pharmacokinetics, and regulation of L-carnitine and acetyl-L-carnitine metabolism.
Rebouche CJ
Ann N Y Acad Sci; 2004 Nov; 1033():30-41. PubMed ID: 15591001
[TBL] [Abstract][Full Text] [Related]
12. Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients.
Brass EP; Adler S; Sietsema KE; Hiatt WR; Orlando AM; Amato A;
Am J Kidney Dis; 2001 May; 37(5):1018-28. PubMed ID: 11325685
[TBL] [Abstract][Full Text] [Related]
13. A comparison of plasma and muscle carnitine levels in patients on peritoneal or hemodialysis for chronic renal failure.
Moorthy AV; Rosenblum M; Rajaram R; Shug AL
Am J Nephrol; 1983; 3(4):205-8. PubMed ID: 6614070
[TBL] [Abstract][Full Text] [Related]
14. L-carnitine addition to dialysis fluid. A therapeutic alternative for hemodialysis patients.
Vacha GM; Giorcelli G; d'Iddio S; Valentini G; Bagiella E; Procopio A; di Donato S; Ashbrook D; Corsi M
Nephron; 1989; 51(2):237-42. PubMed ID: 2915763
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of L-carnitine.
Evans AM; Fornasini G
Clin Pharmacokinet; 2003; 42(11):941-67. PubMed ID: 12908852
[TBL] [Abstract][Full Text] [Related]
16. [Supplementation with high-dose L-carnitine on hemodialysis tolerance in uremic patients with severe heart diseases].
Pan YJ; Lu FP
Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(48):3792-3795. PubMed ID: 29325338
[No Abstract] [Full Text] [Related]
17. Carnitine in maintenance hemodialysis patients.
Guarnieri G
J Ren Nutr; 2015 Mar; 25(2):169-75. PubMed ID: 25600394
[TBL] [Abstract][Full Text] [Related]
18. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
[TBL] [Abstract][Full Text] [Related]
19. Multicenter trial of L-carnitine in maintenance hemodialysis patients. I. Carnitine concentrations and lipid effects.
Golper TA; Wolfson M; Ahmad S; Hirschberg R; Kurtin P; Katz LA; Nicora R; Ashbrook D; Kopple JD
Kidney Int; 1990 Nov; 38(5):904-11. PubMed ID: 2266674
[TBL] [Abstract][Full Text] [Related]
20. Carnitine metabolism in uremia.
Guarnieri G; Situlin R; Biolo G
Am J Kidney Dis; 2001 Oct; 38(4 Suppl 1):S63-7. PubMed ID: 11576925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
